Skip to main content
Top
Published in: Nutrition & Metabolism 1/2022

Open Access 01-12-2022 | Research

Angiotensin(1–7) attenuates visceral adipose tissue expansion and lipogenesis by suppression of endoplasmic reticulum stress via Mas receptor

Authors: Chifa Ma, Tingting Shi, Lini Song, Jingyi Liu, Mingxia Yuan

Published in: Nutrition & Metabolism | Issue 1/2022

Login to get access

Abstract

Background

White adipose tissue can be classified based on its location as subcutaneous and visceral fat, and the latter accumulation is reported to be more detrimental to metabolism. Endoplasmic reticulum (ER) stress has been demonstrated to regulate lipogenesis. The peptide angiotensin(1–7) [Ang(1–7)], which can be produced from angiotensin II (AngII) by angiotensin-converting enzyme 2 (ACE2), plays its role through Mas receptor, also participates in the regulation of lipid metabolism in adipose tissue, however, whether ER stress is involved in the mechanism remains unclear. Therefore, we aimed to explore the role of Ang(1–7) pathway in regulating visceral adipose tissue expansion and ER stress.

Methods

ACE2 knockout (KO), Mas KO and C57BL/6 J mice were fed with high fat diet. Db/db mice were treated with either normal saline, Ang(1–7) or Ang(1–7) combined with Mas receptor inhibitor A779 using mini osmotic pumps. Fat mass was weighted, fat distribution was evaluated by MRI, and lipid profile and adipokines in epididymal adipose tissue were measured by ELISA kits, and histology of epididymal adipose tissue was also analyzed in multiple animal models. Additionally, differentiated 3T3-L1 cells were pre-loaded with palmitic acid to induce ER stress, then treated with drugs as those administrated to db/db mice. ER stress and lipogenesis related proteins in mice adipose and differentiated 3T3L-1 cells were analyzed by Western blot.

Results

ACE2 or Mas KO mice exhibited increased visceral adipose tissue, adipocyte size and protein expression of lipogenesis and ER stress related markers in epididymal adipose tissue compared to wild-type mice. Db/db mice treated with Ang(1–7) displayed decreased visceral fat mass, adipocyte size and protein expression of lipogenesis and ER stress markers in epididymal adipose tissue compared to those treated with normal saline, while A779 partly attenuated these effects. Additionally, Ang(1–7) improved ER stress and lipogenesis markers in differentiated 3T3-L1 cells pre-loaded with palmitic acid.

Conclusions

Our findings indicated that Ang(1–7) attenuated visceral adipose tissue expansion and lipogenesis by suppression of ER stress via Mas receptor. The present study provides a potential perspective for Ang(1–7) for the therapeutics of obesity and related disorders.
Appendix
Available only for authorised users
Literature
1.
go back to reference McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab. 2011;96(11):E1756–60.CrossRef McLaughlin T, Lamendola C, Liu A, Abbasi F. Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity. J Clin Endocrinol Metab. 2011;96(11):E1756–60.CrossRef
2.
go back to reference Liu L, Feng J, Zhang G, Yuan X, Li F, Yang T, et al. Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes. Curr Med Res Opin. 2018;34(1):123–9.CrossRef Liu L, Feng J, Zhang G, Yuan X, Li F, Yang T, et al. Visceral adipose tissue is more strongly associated with insulin resistance than subcutaneous adipose tissue in Chinese subjects with pre-diabetes. Curr Med Res Opin. 2018;34(1):123–9.CrossRef
3.
go back to reference Perez-Torres I, Gutierrez-Alvarez Y, Guarner-Lans V, Diaz-Diaz E, Manzano Pech L, Caballero-Chacon SDC. Intra-abdominal fat adipocyte hypertrophy through a progressive alteration of lipolysis and lipogenesis in metabolic syndrome rats. Nutrients. 2019;11(7). Perez-Torres I, Gutierrez-Alvarez Y, Guarner-Lans V, Diaz-Diaz E, Manzano Pech L, Caballero-Chacon SDC. Intra-abdominal fat adipocyte hypertrophy through a progressive alteration of lipolysis and lipogenesis in metabolic syndrome rats. Nutrients. 2019;11(7).
4.
go back to reference Zhang K. Integration of ER stress, oxidative stress and the inflammatory response in health and disease. Int J Clin Exp Med. 2010;3(1):33–40. Zhang K. Integration of ER stress, oxidative stress and the inflammatory response in health and disease. Int J Clin Exp Med. 2010;3(1):33–40.
5.
go back to reference Han J, Kaufman RJ. The role of ER stress in lipid metabolism and lipotoxicity. J Lipid Res. 2016;57(8):1329–38.CrossRef Han J, Kaufman RJ. The role of ER stress in lipid metabolism and lipotoxicity. J Lipid Res. 2016;57(8):1329–38.CrossRef
6.
go back to reference Menikdiwela KR, Torres Guimaraes JP, Ramalingam L, Kalupahana NS, Dufour JM, Washburn RL, et al. Mechanisms linking endoplasmic reticulum (ER) stress and microRNAs to adipose tissue dysfunction in obesity. Crit Rev Biochem Mol Biol. 2021;56(5):455–81.CrossRef Menikdiwela KR, Torres Guimaraes JP, Ramalingam L, Kalupahana NS, Dufour JM, Washburn RL, et al. Mechanisms linking endoplasmic reticulum (ER) stress and microRNAs to adipose tissue dysfunction in obesity. Crit Rev Biochem Mol Biol. 2021;56(5):455–81.CrossRef
7.
go back to reference Lebeaupin C, Vallee D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018;69(4):927–47.CrossRef Lebeaupin C, Vallee D, Hazari Y, Hetz C, Chevet E, Bailly-Maitre B. Endoplasmic reticulum stress signalling and the pathogenesis of non-alcoholic fatty liver disease. J Hepatol. 2018;69(4):927–47.CrossRef
8.
go back to reference Ajoolabady A, Liu S, Klionsky DJ, Lip GYH, Tuomilehto J, Kavalakatt S, et al. ER stress in obesity pathogenesis and management. Trends Pharmacol Sci. 2022;43(2):97–109.CrossRef Ajoolabady A, Liu S, Klionsky DJ, Lip GYH, Tuomilehto J, Kavalakatt S, et al. ER stress in obesity pathogenesis and management. Trends Pharmacol Sci. 2022;43(2):97–109.CrossRef
9.
go back to reference Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747–803.CrossRef Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86(3):747–803.CrossRef
10.
go back to reference Santos SH, Braga JF, Mario EG, Porto LC, Rodrigues-Machado Mda G, Murari A, et al. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1–7). Arterioscler Thromb Vasc Biol. 2010;30(5):953–61.CrossRef Santos SH, Braga JF, Mario EG, Porto LC, Rodrigues-Machado Mda G, Murari A, et al. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1–7). Arterioscler Thromb Vasc Biol. 2010;30(5):953–61.CrossRef
11.
go back to reference Kalupahana NS, Moustaid-Moussa N. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev. 2012;13(2):136–49.CrossRef Kalupahana NS, Moustaid-Moussa N. The renin-angiotensin system: a link between obesity, inflammation and insulin resistance. Obes Rev. 2012;13(2):136–49.CrossRef
12.
go back to reference Clarke NE, Turner AJ. Angiotensin-converting enzyme 2: the first decade. Int J Hypertens. 2012;2012:307315.CrossRef Clarke NE, Turner AJ. Angiotensin-converting enzyme 2: the first decade. Int J Hypertens. 2012;2012:307315.CrossRef
13.
go back to reference Dibo P, Maranon RO, Chandrashekar K, Mazzuferi F, Silva GB, Juncos LA, et al. Angiotensin-(1–7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb. Physiol Rep. 2019;7(5):e14015.CrossRef Dibo P, Maranon RO, Chandrashekar K, Mazzuferi F, Silva GB, Juncos LA, et al. Angiotensin-(1–7) inhibits sodium transport via Mas receptor by increasing nitric oxide production in thick ascending limb. Physiol Rep. 2019;7(5):e14015.CrossRef
14.
go back to reference Simoes e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angiotensin-(1–7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol. 2013;169(3):477–92.CrossRef Simoes e Silva AC, Silveira KD, Ferreira AJ, Teixeira MM. ACE2, angiotensin-(1–7) and Mas receptor axis in inflammation and fibrosis. Br J Pharmacol. 2013;169(3):477–92.CrossRef
15.
go back to reference Strazzullo P, Galletti F. Impact of the renin-angiotensin system on lipid and carbohydrate metabolism. Curr Opin Nephrol Hypertens. 2004;13(3):325–32.CrossRef Strazzullo P, Galletti F. Impact of the renin-angiotensin system on lipid and carbohydrate metabolism. Curr Opin Nephrol Hypertens. 2004;13(3):325–32.CrossRef
16.
go back to reference Santos SH, Fernandes LR, Mario EG, Ferreira AV, Porto LC, Alvarez-Leite JI, et al. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes. 2008;57(2):340–7.CrossRef Santos SH, Fernandes LR, Mario EG, Ferreira AV, Porto LC, Alvarez-Leite JI, et al. Mas deficiency in FVB/N mice produces marked changes in lipid and glycemic metabolism. Diabetes. 2008;57(2):340–7.CrossRef
17.
go back to reference Marcus Y, Shefer G, Sasson K, Kohen F, Limor R, Pappo O, et al. Angiotensin 1–7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes. 2013;62(4):1121–30.CrossRef Marcus Y, Shefer G, Sasson K, Kohen F, Limor R, Pappo O, et al. Angiotensin 1–7 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes. 2013;62(4):1121–30.CrossRef
18.
go back to reference Cao X, Lu XM, Tuo X, Liu JY, Zhang YC, Song LN, et al. Angiotensin-converting enzyme 2 regulates endoplasmic reticulum stress and mitochondrial function to preserve skeletal muscle lipid metabolism. Lipids Health Dis. 2019;18(1):207.CrossRef Cao X, Lu XM, Tuo X, Liu JY, Zhang YC, Song LN, et al. Angiotensin-converting enzyme 2 regulates endoplasmic reticulum stress and mitochondrial function to preserve skeletal muscle lipid metabolism. Lipids Health Dis. 2019;18(1):207.CrossRef
19.
go back to reference Cao X, Song LN, Zhang YC, Li Q, Shi TT, Yang FY, et al. Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease. Diabetes Metab Res Rev. 2019;35(4):e3123.CrossRef Cao X, Song LN, Zhang YC, Li Q, Shi TT, Yang FY, et al. Angiotensin-converting enzyme 2 inhibits endoplasmic reticulum stress-associated pathway to preserve nonalcoholic fatty liver disease. Diabetes Metab Res Rev. 2019;35(4):e3123.CrossRef
20.
go back to reference Zhang M, Gao Y, Zhao W, Yu G, Jin F. ACE-2/ANG1-7 ameliorates ER stress-induced apoptosis in seawater aspiration-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2018;315(6):L1015–27.CrossRef Zhang M, Gao Y, Zhao W, Yu G, Jin F. ACE-2/ANG1-7 ameliorates ER stress-induced apoptosis in seawater aspiration-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2018;315(6):L1015–27.CrossRef
21.
go back to reference Sukumaran V, Veeraveedu PT, Gurusamy N, Yamaguchi K, Lakshmanan AP, Ma M, et al. Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1–7/mas receptor axis. Int J Biol Sci. 2011;7(8):1077–92.CrossRef Sukumaran V, Veeraveedu PT, Gurusamy N, Yamaguchi K, Lakshmanan AP, Ma M, et al. Cardioprotective effects of telmisartan against heart failure in rats induced by experimental autoimmune myocarditis through the modulation of angiotensin-converting enzyme-2/angiotensin 1–7/mas receptor axis. Int J Biol Sci. 2011;7(8):1077–92.CrossRef
22.
go back to reference Song LN, Liu JY, Shi TT, Zhang YC, Xin Z, Cao X, et al. Angiotensin-(1–7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism. FASEB J. 2020;34(12):16291–306.CrossRef Song LN, Liu JY, Shi TT, Zhang YC, Xin Z, Cao X, et al. Angiotensin-(1–7), the product of ACE2 ameliorates NAFLD by acting through its receptor Mas to regulate hepatic mitochondrial function and glycolipid metabolism. FASEB J. 2020;34(12):16291–306.CrossRef
23.
go back to reference Tang Y, Lee S, Nelson MD Jr, Richard S, Moats RA. Adipose segmentation in small animals at 7T: a preliminary study. BMC Genom. 2010;11(Suppl 3):S9. Tang Y, Lee S, Nelson MD Jr, Richard S, Moats RA. Adipose segmentation in small animals at 7T: a preliminary study. BMC Genom. 2010;11(Suppl 3):S9.
24.
go back to reference Magdalon J, Chimin P, Belchior T, Neves RX, Vieira-Lara MA, Andrade ML, et al. Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice. Biochim Biophys Acta. 2016;1861(5):430–8.CrossRef Magdalon J, Chimin P, Belchior T, Neves RX, Vieira-Lara MA, Andrade ML, et al. Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice. Biochim Biophys Acta. 2016;1861(5):430–8.CrossRef
25.
go back to reference Kavalakatt S, Khadir A, Madhu D, Koistinen HA, Al-Mulla F, Tuomilehto J, et al. Urocortin 3 overexpression reduces ER stress and heat shock response in 3T3-L1 adipocytes. Sci Rep. 2021;11(1):15666.CrossRef Kavalakatt S, Khadir A, Madhu D, Koistinen HA, Al-Mulla F, Tuomilehto J, et al. Urocortin 3 overexpression reduces ER stress and heat shock response in 3T3-L1 adipocytes. Sci Rep. 2021;11(1):15666.CrossRef
26.
go back to reference Liu C, Lv XH, Li HX, Cao X, Zhang F, Wang L, et al. Angiotensin-(1–7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes. Acta Diabetol. 2012;49(4):291–9.CrossRef Liu C, Lv XH, Li HX, Cao X, Zhang F, Wang L, et al. Angiotensin-(1–7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes. Acta Diabetol. 2012;49(4):291–9.CrossRef
27.
go back to reference Cao X, Shi TT, Zhang CH, Jin WZ, Song LN, Zhang YC, et al. ACE2 pathway regulates thermogenesis and energy metabolism. Elife. 2022;11. Cao X, Shi TT, Zhang CH, Jin WZ, Song LN, Zhang YC, et al. ACE2 pathway regulates thermogenesis and energy metabolism. Elife. 2022;11.
28.
go back to reference Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477–81.CrossRef Hashimoto T, Perlot T, Rehman A, Trichereau J, Ishiguro H, Paolino M, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477–81.CrossRef
29.
go back to reference Elattar S, Satyanarayana A. Can brown fat win the battle against white fat? J Cell Physiol. 2015;230(10):2311–7.CrossRef Elattar S, Satyanarayana A. Can brown fat win the battle against white fat? J Cell Physiol. 2015;230(10):2311–7.CrossRef
30.
go back to reference Benatti FB, Lira FS, Oyama LM, do Nascimento CM, Lancha AH Jr. Strategies for reducing body fat mass: effects of liposuction and exercise on cardiovascular risk factors and adiposity. Diabetes Metab Syndr Obes. 2011;4:141–54.CrossRef Benatti FB, Lira FS, Oyama LM, do Nascimento CM, Lancha AH Jr. Strategies for reducing body fat mass: effects of liposuction and exercise on cardiovascular risk factors and adiposity. Diabetes Metab Syndr Obes. 2011;4:141–54.CrossRef
31.
go back to reference de Macedo SM, Guimarares TA, Andrade JM, Guimaraes AL, Batista de Paula AM, Ferreira AJ, et al. Angiotensin converting enzyme 2 activator (DIZE) modulates metabolic profiles in mice, decreasing lipogenesis. Protein Pept Lett. 2015;22(4):332–40.CrossRef de Macedo SM, Guimarares TA, Andrade JM, Guimaraes AL, Batista de Paula AM, Ferreira AJ, et al. Angiotensin converting enzyme 2 activator (DIZE) modulates metabolic profiles in mice, decreasing lipogenesis. Protein Pept Lett. 2015;22(4):332–40.CrossRef
32.
go back to reference Isakson P, Hammarstedt A, Gustafson B, Smith U. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes. 2009;58(7):1550–7.CrossRef Isakson P, Hammarstedt A, Gustafson B, Smith U. Impaired preadipocyte differentiation in human abdominal obesity: role of Wnt, tumor necrosis factor-alpha, and inflammation. Diabetes. 2009;58(7):1550–7.CrossRef
33.
go back to reference Zhu W, Niu X, Wang M, Li Z, Jiang HK, Li C, et al. Endoplasmic reticulum stress may be involved in insulin resistance and lipid metabolism disorders of the white adipose tissues induced by high-fat diet containing industrial trans-fatty acids. Diabetes Metab Syndr Obes. 2019;12:1625–38.CrossRef Zhu W, Niu X, Wang M, Li Z, Jiang HK, Li C, et al. Endoplasmic reticulum stress may be involved in insulin resistance and lipid metabolism disorders of the white adipose tissues induced by high-fat diet containing industrial trans-fatty acids. Diabetes Metab Syndr Obes. 2019;12:1625–38.CrossRef
34.
go back to reference Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306(5695):457–61.CrossRef Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, Ozdelen E, et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004;306(5695):457–61.CrossRef
35.
go back to reference Zhou L, Liu F. Autophagy: roles in obesity-induced ER stress and adiponectin downregulation in adipocytes. Autophagy. 2010;6(8):1196–7.CrossRef Zhou L, Liu F. Autophagy: roles in obesity-induced ER stress and adiponectin downregulation in adipocytes. Autophagy. 2010;6(8):1196–7.CrossRef
36.
go back to reference Song G, Wu X, Zhang P, Yu Y, Yang M, Jiao P, et al. High-density lipoprotein inhibits ox-LDL-induced adipokine secretion by upregulating SR-BI expression and suppressing ER stress pathway. Sci Rep. 2016;6:30889.CrossRef Song G, Wu X, Zhang P, Yu Y, Yang M, Jiao P, et al. High-density lipoprotein inhibits ox-LDL-induced adipokine secretion by upregulating SR-BI expression and suppressing ER stress pathway. Sci Rep. 2016;6:30889.CrossRef
37.
go back to reference Baba B, Caliskan M, Boyuk G, Hacisevki A. Chemical chaperone PBA attenuates ER stress and upregulates SOCS3 expression as a regulator of leptin signaling. Biochem Mosc. 2021;86(4):480–8.CrossRef Baba B, Caliskan M, Boyuk G, Hacisevki A. Chemical chaperone PBA attenuates ER stress and upregulates SOCS3 expression as a regulator of leptin signaling. Biochem Mosc. 2021;86(4):480–8.CrossRef
38.
go back to reference Hosoi T, Sasaki M, Miyahara T, Hashimoto C, Matsuo S, Yoshii M, et al. Endoplasmic reticulum stress induces leptin resistance. Mol Pharmacol. 2008;74(6):1610–9.CrossRef Hosoi T, Sasaki M, Miyahara T, Hashimoto C, Matsuo S, Yoshii M, et al. Endoplasmic reticulum stress induces leptin resistance. Mol Pharmacol. 2008;74(6):1610–9.CrossRef
39.
go back to reference Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS. Leptin in human physiology and therapeutics. Front Neuroendocrinol. 2010;31(3):377–93.CrossRef Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS. Leptin in human physiology and therapeutics. Front Neuroendocrinol. 2010;31(3):377–93.CrossRef
Metadata
Title
Angiotensin(1–7) attenuates visceral adipose tissue expansion and lipogenesis by suppression of endoplasmic reticulum stress via Mas receptor
Authors
Chifa Ma
Tingting Shi
Lini Song
Jingyi Liu
Mingxia Yuan
Publication date
01-12-2022
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2022
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/s12986-022-00716-x

Other articles of this Issue 1/2022

Nutrition & Metabolism 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine